Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abdulla, 1998, Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons, J Neurosci, 18, 9685, 10.1523/JNEUROSCI.18-23-09685.1998
Al-Hasani, 2011, Molecular mechanisms of opioid receptor-dependent signaling and behavior, Anesthesiology, 115, 1363, 10.1097/ALN.0b013e318238bba6
Armstead, 2002, NOC/oFQ activates PKC and generates superoxide to impair hypotensive cerebrovasodilation after hypoxia/ischemia, Med Sci Monit, 8, BR8
Calò G Guerrini R (2013) Medicinal chemistry, pharmacology, and biological actions of peptide ligands selective for teh nociceptin/orphanin FQ receptor, in Research and Development of Opioid-Related Ligands ( Ko MC Husbands SM , eds) pp 275–325, Oxford University Press, Washington, DC.
Calò, 2005, UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor, CNS Drug Rev, 11, 97, 10.1111/j.1527-3458.2005.tb00264.x
Chan, 2000, Regulation of c-Jun N-terminal kinase by the ORL(1) receptor through multiple G proteins, J Pharmacol Exp Ther, 295, 1094
Chan, 1998, Pertussis toxin-insensitive signaling of the ORL1 receptor: coupling to Gz and G16 proteins, J Neurochem, 71, 2203, 10.1046/j.1471-4159.1998.71052203.x
Combie, 1981, Pharmacology of narcotic analgesics in the horse: selective blockade of narcotic-induced locomotor activity, Am J Vet Res, 42, 716
Daga, 2012, Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation, Proteins, 80, 1948, 10.1002/prot.24077
Dautzenberg, 2001, Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo, J Pharmacol Exp Ther, 298, 812
Davis, 1999, d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia, J Pharmacol Exp Ther, 289, 1048
Dooley, 1997, Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1, J Pharmacol Exp Ther, 283, 735
Fukuda, 1998, Activation of phospholipase A2 by the nociceptin receptor expressed in Chinese hamster ovary cells, J Neurochem, 71, 2186, 10.1046/j.1471-4159.1998.71052186.x
Goldstein, 1969, Tolerance to opioid narcotics. I. Tolerance to the “running fit” caused by levorphanol in the mouse, J Pharmacol Exp Ther, 169, 175
Hawes, 1998, Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization, J Neurochem, 71, 1024, 10.1046/j.1471-4159.1998.71031024.x
Huang, 2001, Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist, J Pharmacol Exp Ther, 297, 688
Johnson, 1992, Opioids excite dopamine neurons by hyperpolarization of local interneurons, J Neurosci, 12, 483, 10.1523/JNEUROSCI.12-02-00483.1992
Judson, 1978, Genetic control of opiate-induced locomotor activity in mice, J Pharmacol Exp Ther, 206, 56
Kallupi, 2014, MT-7716, a novel selective nonpeptidergic NOP receptor agonist, effectively blocks ethanol-induced increase in GABAergic transmission in the rat central amygdala, Front Integr Neurosci, 8, 18, 10.3389/fnint.2014.00018
Lachowicz, 1995, Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family, J Neurochem, 64, 34, 10.1046/j.1471-4159.1995.64010034.x
Lester, 2006, Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes, Brain Res, 1073-1074, 290, 10.1016/j.brainres.2005.12.066
Lou, 1998, Nociceptin/orphanin FQ activates mitogen-activated protein kinase in Chinese hamster ovary cells expressing opioid receptor-like receptor, J Neurochem, 70, 1316, 10.1046/j.1471-4159.1998.70031316.x
Lutfy, 2003, Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors, J Neurosci, 23, 10331, 10.1523/JNEUROSCI.23-32-10331.2003
Molinari S, Malfacini D, Camarda V, Trapella C, Guerrini R, Mustazza C, and Calo G (2012) In vitro pharmacological characterization of the non peptide NOP receptor agonists Ro 65-6570, SCH-221510 and Compound 6d, in BPS Focused Meeting on Neuropeptides, http://www.pa2online.org, King's College London, UK.
Nugent, 1982, Effects of enkephalins versus opiates on locomotor activity of the horse, Res Commun Chem Pathol Pharmacol, 35, 405
Pan, 1995, Cloning and functional characterization through antisense mapping of a κ 3-related opioid receptor, Mol Pharmacol, 47, 1180
Post A Smart TS Krikke-Workel J Dawson GR Harmer CJ Browning M Jackson K Kakar R Mohs R Statnick M (2015) A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies. Neuropsychopharmacology, in press.
Rutten, 2011, Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats, Drug Alcohol Depend, 114, 253
Stayte, 2014, Advances in non-dopaminergic treatments for Parkinson’s disease, Front Neurosci, 8, 113
Tancredi, 2005, The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ, Chemistry, 11, 2061, 10.1002/chem.200401095
Vaughan, 1997, Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro, J Neurosci, 17, 996, 10.1523/JNEUROSCI.17-03-00996.1997
Wang, 1996, Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli, J Neurophysiol, 76, 3568, 10.1152/jn.1996.76.5.3568
Wickman, 1995, Ion channel regulation by G proteins, Physiol Rev, 75, 865, 10.1152/physrev.1995.75.4.865
Xu, 1996, Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat, Neuroreport, 7, 2092
Yoshimura, 1989, Primary afferent-evoked synaptic responses and slow potential generation in rat substantia gelatinosa neurons in vitro, J Neurophysiol, 62, 96, 10.1152/jn.1989.62.1.96
Yung, 1999, GalphaL1 (Galpha14) couples the opioid receptor-like1 receptor to stimulation of phospholipase C, J Pharmacol Exp Ther, 288, 232
Zaki, 2000, Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?, J Pharmacol Exp Ther, 292, 1127